Athersys Inc. (Nasdaq: ATHX), a biopharmaceutical company focused on developing an innovative stem cell platform, similar to companies like Mesoblast (MSB: ASX), Osiris (Nasdaq: OSIR) and ThermoGenesis Corp (Nasdaq: KOOL), recently announced that its CEO would deliver the keynote address at the World Stem Cell Summit 2011.
Recent Posts
- World-first stem-cell treatment restores vision in people
- Human stem cell-derived heart cells are safe in monkeys, could treat congenital heart disease
- Markers in iPSC quality control—a new approach to enhance standardization
- Nasal Spray Made From Stem Cells Could Treat Alzheimer’s Disease
- New Stem Cell Data From Space
- Stem cells reveal how exposure to danger signals primes immune response in cardiovascular disease